UMediC Group Berhad Cash Flow Conversion Efficiency

Latest as of October 2025: -0.034x

UMediC Group Berhad cash flow conversion efficiency. Based on the latest financial reports, UMediC Group Berhad (0256) has a cash flow conversion efficiency ratio of -0.034x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-2.80 Million ≈ $-702.49K USD) by net assets (RM83.20 Million ≈ $20.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of UMediC Group Berhad (2020–2025)

Cash flow conversion efficiency of UMediC Group Berhad from 2020 to 2025. This chart illustrates how UMediC Group Berhad's cash flow conversion efficiency has evolved over time, based on yearly financial data. View UMediC Group Berhad share price for real-time trading data and today's change.

UMediC Group Berhad Cash Flow Conversion Ratio Explained

UMediC Group Berhad cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

UMediC Group Berhad Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of UMediC Group Berhad ranked by their cash flow conversion efficiency. Also see 0256 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Aetherium Acquisition Corp NASDAQ:GMFI	N/A
Yung Zip Chemical Ind Co Ltd TWO:4102	-0.018x
Camellia Metal Co Ltd TWO:2064	0.107x
Demire Deutsche Mittelstand Real Estate AG F:DMRE	-0.002x
Transtema Group AB ST:TRANS	-0.006x
Cheetah Mobile Inc NYSE:CMCM	-0.096x
Lysaght Galvanized Steel Bhd KLSE:9199	-0.018x
Deep Value Driller AS OL:DVD	1.304x

Annual Cash Flow Conversion Efficiency for UMediC Group Berhad (2020–2025)

The table below shows the annual cash flow conversion efficiency of UMediC Group Berhad from 2020 to 2025. Review cash generation quality of UMediC Group Berhad to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-07-31	RM81.35 Million ≈ $20.42 Million	RM11.18 Million ≈ $2.81 Million	0.137x	+131.41%
2024-07-31	RM72.77 Million ≈ $18.27 Million	RM4.32 Million ≈ $1.09 Million	0.059x	+109.05%
2023-07-31	RM63.48 Million ≈ $15.94 Million	RM1.80 Million ≈ $452.94K	0.028x	-82.34%
2022-07-31	RM52.68 Million ≈ $13.23 Million	RM8.48 Million ≈ $2.13 Million	0.161x	-30.61%
2021-07-31	RM15.74 Million ≈ $3.95 Million	RM3.65 Million ≈ $916.46K	0.232x	+139.33%
2020-07-31	RM6.63 Million ≈ $1.67 Million	RM-3.91 Million ≈ $-981.91K	-0.590x	--

About UMediC Group Berhad

KLSE:0256 Malaysia Medical Devices

Market Cap

$24.88 Million

RM99.09 Million MYR

Market Cap Rank

#24261 Global

#625 in Malaysia

Share Price

RM0.27

Change (1 day)

-3.64%

52-Week Range

RM0.26 - RM0.44

All Time High

RM0.89